Commercial Court

SAR - LOCAFRIQUE designated sacrificial lamb

Retrieved on: 
Wednesday, December 29, 2021
State, Organization, African, Harmonization, CFA, Board, Commercial Court (England and Wales), SAR, OHADA, Textbook, Knowledge, NEWS, Hearing, Corporate law, Intelligence, Director, Commercial Court, Face, Life insurance, Petroleum, Léopold Sédar Senghor

Senghor knew and had warned accordingly, leaving it to the succession to make good use of it.

Key Points: 
  • Senghor knew and had warned accordingly, leaving it to the succession to make good use of it.
  • At a time when the exploitation of oil and gas is announced in the next two or three years, questions may arise about the appetites and conduct of the SAR.
  • It cannot do otherwise in the face of the State's declared will after having done the most difficult thing, i.e.
  • It is even said that LOCAFRIQUE has largely contributed to cushioning the financial shocks in 2021 so that the African Refining Company can make profitable margins.

DGAP-News: Complaint: Locafrique claims 170 billion from SAR before the English courts

Retrieved on: 
Friday, December 24, 2021
DGAP, AFC, Commercial Court (England and Wales), London, CFA, London Court, Commercial Court, FCFA, Complaint, SAR, Lawyer, Contract, News, Security (finance), Online gambling

The company Locafrique ( www.Locafrique-sf.com ) is claiming 170 billion from Socit Africaine de Raffinage (SAR) and a complaint has been filed with the London Court of Appeal, according to their lawyers.

Key Points: 
  • The company Locafrique ( www.Locafrique-sf.com ) is claiming 170 billion from Socit Africaine de Raffinage (SAR) and a complaint has been filed with the London Court of Appeal, according to their lawyers.
  • Mr. Seydou Diagne, El Hadj Diouf and Dmba Cir Bathily made the announcement at a press conference on Wednesday.
  • According to the explanations of Mr. Seydou Diagne, the choice of English jurisdictions was made in perfect adequacy with the contracts that bind the company Locafrique, its partners and SAR.
  • These two companies wanted to go through AFC at all costs in order to raise 192 billion CFA francs and recapitalise SAR.

Acerus Reports Fiscal Third Quarter Financial Results

Retrieved on: 
Tuesday, November 9, 2021
Lesbian flag, Adjustment, Three Months in the Southern States, International Financial Reporting Standards, Health Canada, Commercial Court, Orange Book, English Civil War, Failure, Income, Growth, Depreciation, COVID-19, IFRS, Face, Research, International, GBP, ASP, File, TSX, Twitter, Income tax, Prescription, Company, Toxicology, GLOBE, LinkedIn, API, Budget, OTCQB, Recipharm, Patent, SWK, Pharmaceutical industry, Animal, Reinsurance, Bookkeeping, Security (finance)

TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2021.

Key Points: 
  • TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2021.
  • Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (IFRS).
  • Neither of these issues, though, is expected to greatly impact our results in the fourth quarter, and so we are optimistic about the business heading into 2022.
  • The Company faced some headwinds in the fiscal 2021 third quarter that impacted total prescription volume and subsequent revenue growth, including a temporary increase in COVID-19 restrictions and, to a lesser extent, constraints in hiring qualified staff; both issues are not anticipated to materially impact fourth quarter results.

Plainview-based Didit DM Agency Expands Operations With Move to New Facility in Lindenhurst

Retrieved on: 
Tuesday, September 28, 2021
Marketing, Public relations, Postcard, Operation, Commercial Court, Growth, Printing, Industry, Online shopping

In the current marketplace, Didit DM has been able to maintain a stable foothold in the direct mail industry, and the company projects continued growth in business.

Key Points: 
  • In the current marketplace, Didit DM has been able to maintain a stable foothold in the direct mail industry, and the company projects continued growth in business.
  • The new location's space and layout will effectively meet the current needs of the company and its clients.
  • "Didit DM has been able to maintain its substantial growth rate through its high-quality service, combined with the forward-thinking approach of linking a printing and mailing house with our parent company, Didit Digital, a cutting-edge, multi-service agency," notes Didit Chief Executive Officer and Co-Founder Dave Pasternack.
  • Didit was co-founded by SEO/SEM thought leader, SEMPO founding board member, and Didit Executive ChairmanKevin Lee.

Further support for International Business in Qatar's Free Zones

Retrieved on: 
Wednesday, September 22, 2021
Middle East nuclear weapon free zone, Policy, Commercial Court, Amiri Diwan of the State of Qatar, Independent Pricing and Regulatory Tribunal of New South Wales, Regulatory agency, Court, Civil, Telecommunications Regulatory Authority of Lebanon, QFC, Economic development, Investment, United Kingdom, Natural gas, Cryptocurrency, Property management

DOHA, Qatar, Sept. 22, 2021 /PRNewswire/ -- As part of Qatar's strategy to attract international business and financial services to Qatar, the jurisdiction of the Qatar International Court and Dispute Resolution Centre (QICDRC) has been expanded to include the Qatar Free Zones and the Qatar Free Zones Authority (QFZA) as well as matters referred to the Court or Regulatory tribunal by any Law in the State.

Key Points: 
  • QICDRC CEO Faisal Al-Sahouti said: "Our expansion to support the Qatar Free Zones Authority will build on Qatar's role as a global business destination and highlights QICDRC's contribution to the international legal community and international justice.
  • Our support for the free zone adds to the benefits of the free zones ensuring further investments with the security of a functioning legal dispute resolution mechanism."
  • Upholding international standards in dispute resolution,QICDRC ispart of the State of Qatar's strategy to attract international business and financial services to Qatar.
  • Qatar Free Zones current cluster consist of Ras Boufantas (airport free zone) and Umm AlHoul (port free zone).

Further support for International Business in Qatar's Free Zones

Retrieved on: 
Wednesday, September 22, 2021
Middle East nuclear weapon free zone, Policy, Commercial Court, Amiri Diwan of the State of Qatar, Independent Pricing and Regulatory Tribunal of New South Wales, Regulatory agency, Court, Civil, Telecommunications Regulatory Authority of Lebanon, QFC, Economic development, Investment, United Kingdom, Natural gas, Cryptocurrency, Property management

QICDRC CEO Faisal Al-Sahouti said: "Our expansion to support the Qatar Free Zones Authority will build on Qatar's role as a global business destination and highlights QICDRC's contribution to the international legal community and international justice.

Key Points: 
  • QICDRC CEO Faisal Al-Sahouti said: "Our expansion to support the Qatar Free Zones Authority will build on Qatar's role as a global business destination and highlights QICDRC's contribution to the international legal community and international justice.
  • Our support for the free zone adds to the benefits of the free zones ensuring further investments with the security of a functioning legal dispute resolution mechanism."
  • Upholding international standards in dispute resolution,QICDRC ispart of the State of Qatar's strategy to attract international business and financial services to Qatar.
  • Qatar Free Zones current cluster consist of Ras Boufantas (airport free zone) and Umm AlHoul (port free zone).

Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March 16, 2021 and July 16, 2021

Retrieved on: 
Friday, August 13, 2021
Sarcopenia, Enforcement, Forward-looking statement, U.S. Securities and Exchange Commission, Les francs-juges, Commercial Court, Judgement, American depositary receipt, Ageing, Degenerative disease, Justice, Company, COVID-19, DMD, GLOBE, Treasury, Tribunal, SEC, Lucia v. Securities and Exchange Commission, Failure, Ticker, Annual report, Security (finance), Court, Patient, Review, Euronext Growth, Duchenne muscular dystrophy, ADS, Therapy, Code, Animal, Life insurance, Property management, Pharmaceutical industry

As part of this performance, Biophytis issued 4,950,000 new shares to Negma, in connection with a capital increase reserved for Negma pursuant to the 13th delegation of the general meeting of May 10, 2021.

Key Points: 
  • As part of this performance, Biophytis issued 4,950,000 new shares to Negma, in connection with a capital increase reserved for Negma pursuant to the 13th delegation of the general meeting of May 10, 2021.
  • Biophytis has fulfilled all of its obligations under the two abovementioned judgments.
  • As a result of the issuance of these new shares, Biophytis' capital was increased to 122,145,455 shares, representing a dilution of 4.2%.
  • The forward-looking statements contained in this press release are also subject to risks not yet known to Biophytis or not currently considered material by Biophytis.

Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation

Retrieved on: 
Thursday, August 12, 2021
Commercial, First English Civil War, GLOBE, Commercial Court, ASP, LinkedIn, Judgement, OTCQB, Company, Part, GBP, TSX, Twitter, Pharmaceutical industry

TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made by Recipharm Limited (Recipharm), a wholly-owned subsidiary of Recipharm AB.

Key Points: 
  • TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made by Recipharm Limited (Recipharm), a wholly-owned subsidiary of Recipharm AB.
  • On June 18, 2020, Acerus announced it had commenced litigation against Recipharm in the Commercial Court of London.
  • On July 6, 2021, Recipharm made an offer to settle pursuant to Part 36 of the English Civil Procedure Rules.
  • In addition, Acerus will be entitled to payment of the majority of its costs of the litigation.

Acerus Reports Fiscal 2021 Second Quarter Financial Results

Retrieved on: 
Tuesday, August 10, 2021
TSX, Insurance, Research, Commercial Court, OTCQB, Income, Marketing, Prescription, International, Three Months Gone, Pharmacy benefit management, ASP, Endocrinology, Pharmacy, Growth, Twitter, NDS, Sale, Depreciation, LinkedIn, GLOBE, PBM, Budget, Recipharm, Man, Hypogonadism, Company, Adjustment, SWK, International Financial Reporting Standards, IFRS, Income tax, Pharmaceutical industry, Video game, Health insurance, Animal, Bookkeeping

TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and six-month period ended June 30, 2021.

Key Points: 
  • TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and six-month period ended June 30, 2021.
  • Gross profit was $0.5 million in the second quarter of 2021 versus a gross loss of $0.1 million in 2020.
  • Second quarter research and development ("R&D") expenses were $0.9 million versus $0.4 million in the prior-year period.
  • Second quarter earnings before interest, tax, depreciation and amortization (EBITDA)1 was a loss of $6.5 million compared to a loss of $4.9 million in the second quarter of 2020.